Atlanta, GA, United States of America

Gianna Branella

This inventor holds 1 USPTO granted patent. Top assignee: Emory University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gianna Branella. Retrieved from https://idiyas.com/inventor/gianna-branella

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gianna Branella: Innovator in Hematopoietic Cell Research

Introduction

Gianna Branella is a prominent inventor based in Atlanta, GA. She has made significant contributions to the field of hematopoietic cell research. Her innovative work has led to the development of a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Gianna holds a patent titled "Compositions and Methods for Promoting Hematopoietic Cell Cytotoxicity." This patent reflects her commitment to enhancing the understanding and treatment of hematopoietic cells, which play a crucial role in the immune system.

Career Highlights

Gianna is affiliated with Emory University, where she continues to engage in groundbreaking research. Her work at this esteemed institution allows her to collaborate with other experts in the field and contribute to significant advancements in medical research.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Gianna Branella is a remarkable inventor whose work in hematopoietic cell research is paving the way for future innovations in medicine. Her dedication and expertise are evident in her patent and her role at Emory University.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…